Pyxis oncology stock prediction.
Pyxis Oncology Inc (PYXS) stock is higher by 8.35% while the S&P 500 has fallen -0.1% as of 11:49 AM on Monday, Apr 3. PYXS is higher by $0.33 from the previous closing price of $4.01 on volume of 6,295,868 shares. Over the past year the S&P 500 is down -10.42% while PYXS is higher by 21.17%. PYXS lost -$3.65 per share the over the last 12 months.
As of September 30, 2023, the outstanding number of shares of common stock of Pyxis Oncology was 44,294,092. About Pyxis Oncology, Inc. Pyxis Oncology, Inc. is a clinical-stage company focused on ...PYXS Stock 12 Months Forecast. Based on 4 Wall Street analysts offering 12 month price targets for Pyxis Oncology in the last 3 months. The average price target is $11.67 with a high forecast of $15.00 and a low forecast of $7.00. The average price target represents a 618.15% change from the last price of $1.63.Find the latest Pyxis Oncology, Inc. (PYXS) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Fundamentals There is no chart data available for this period 1d 1w 1m 3m 6m 1y All Latest 3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here or …... shares outstanding. -$2.55. CAPs Rating. The percentage of Motley Fool CAPS user ratings that predict this company will outperform the market. Based on ...
Pyxis Oncology has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings. Price Target Upside/Downside. According to analysts' consensus price target of $8.33, Pyxis Oncology has a forecasted upside of 411.2% from its current price of $1.63.1,003,921 Shares . Common Stock . This prospectus relates to an aggregate of up to 1,003,921 shares of common stock, par value $0.001 per share (our “Common Stock”), of Pyxis Oncology, Inc. (“Pyxis Oncology,” the “Company,” or “we”), issuable upon the future exercise of certain outstanding warrants (collectively, the “Apexigen Warrants”) to purchase shares of common stock ...The stock options have a ten-year term and an exercise price of $4.01, the closing price of Pyxis Oncology’s common stock as reported by Nasdaq on March 31, 2023. Pyxis Oncology is providing ...
Tesla’s stock is predicted to increase in value in 2015, according to Forbes. In January 2015, Forbes noted that Tesla Motors, Inc.
People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.See Pyxis Oncology, Inc. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy.The stock options have a ten-year term and an exercise price of $2.56, the closing price of Pyxis Oncology’s common stock as reported by Nasdaq on June 30, 2023. Pyxis Oncology is providing this information in accordance with Nasdaq Listing Rule 5635(c)(4). About Pyxis Oncology, Inc.Our pipeline. We are focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve the quality of life of patients. We have built a broad portfolio of clinical assets, including novel ADC and mAb product candidates that we are developing as monotherapies and in combination with other therapies.APX801 is an NK cell engager designed to specifically activate natural killer cells leading to effective killing of tumor cells currently at the pre-clinical stage. APX801 was obtained as part of Pyxis Oncology’s acquisition of Apexigen in August 2023 and its development was previously paused by Apexigen. Pyxis, a multiplatform company, is ...
As of December 31, 2022, Pyxis Oncology had cash and cash equivalents (including restricted cash) of $180.7 million, which is expected to fund operations into the first half of 2025.
Pyxis Oncology (PYXS) Stock Price, News & Analysis $1.44 +0.01 (+0.70%) (As of 11/20/2023 ET) Compare Share Today's Range $1.42 $1.48 50-Day …
Real time Pyxis Oncology (PYXS) stock price quote, stock graph, news & analysis.321 Harrison Avenue 11 th Floor, Suite 1 Boston, MA 02118 (617) 453-3596 | [email protected]. Pyxis Oncology, Inc. engages in the business of developing a multi-modality portfolio of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. The firm focuses on the development of product candidates to directly kill tumor cells and to address the underlying pathologies ...BOSTON, May 11, 2023 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company focused on developing next-generation …May 24, 2023 · Pfizer backed Pyxis Oncology (NASDAQ:PYXS) is acquiring Apexigen (NASDAQ:APGN) in an all stock deal, for a total enterprise value of ~$16M. Under the agreement, Pyxis will acquire Apexigen for an ... Feb 13, 2023 · As of February 13, 2023, the average one-year price target for Pyxis Oncology is $11.22. The forecasts range from a low of $4.04 to a high of $16.80. The average price target represents an ...
BOSTON, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers ...Pyxis Oncology, Inc. Common Stock (PYXS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.News releases. Year. 2023. Nov 28, 2023. Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer. Nov 07, 2023. Pyxis Oncology Announces Initiatives to Prioritize Lead ADC Program; Reports Financial Results for Third-Quarter 2023 and Provides Corporate Update. Sep 27, 2023.Mar 22, 2023 · Full-Year 2022 Financial Results. As of December 31, 2022, Pyxis Oncology had cash and cash equivalents (including restricted cash) of $180.7 million, which is expected to fund operations into the ... Pyxis Oncology stock was originally listed at a price of $13.20 in Oct 8, 2021. If you had invested in Pyxis Oncology stock at $13.20, your return over the last 2 years would have been -86.82%, for an annualized return of -63.69% (not including any dividends or …Asset Growth. -27.76%. Trailing 12-Months. The Pyxis Oncology stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and ...Fundamentals. 3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here. Track Pyxis Oncology Inc (PYXS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors.
Pyxis Oncology, Inc. (PYXS) Share Price Forecast v/s Share Price Today Below is a chart showing the percentage difference between Pyxis Oncology, Inc.'s share price and its median forecast price. As on 27.11.23, the difference is -75.29%Zacks Investment Research is releasing its prediction for PYXS based on the 1-3 month trading system that more than doubles the S&P 500. ... to Get Acquired by Pyxis Oncology, Stock Up 05/25/23-2 ...
Pyxis Oncology, Inc. (NasdaqGS:PYXS) completed the acquisition of Apexigen, Inc. (NasdaqCM:APGN) from entities associated with Pfizer Inc. (NYSE:PFE), …(RTTNews) - Pyxis Oncology Inc. (PYXS) said Thursday that it has received clearance for its two Investigational New Drug or IND applications from the U.S. Food and Drug Administration to initiate ...Dec 1, 2023 · Analyst Price Forecast Suggests 349.06% Upside As of November 27, 2023, the average one-year price target for Pyxis Oncology is 7.14. The forecasts range from a low of 5.05 to a high of $9.45. Pyxis Oncology (PYXS) Stock Forecast & Price Prediction. Estimation of the future price movement of Pyxis Oncology stock, based on various factors such as ...Pyxis Oncology, Inc. $ 1.625000 $ 0.06 (3.50%) Trade Now Your capital is at risk. Other fees may apply. Overview Brokers News Prediction Dividend Earnings Pyxis …Forecast. PYXS technical analysis. This gauge displays a real-time technical ... Stock Screener · Forex Screener · Crypto Pairs Screener · Crypto Coins Screener ...Pyxis Oncology Inc (US:PYXS) has 85 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 9,214,235 shares. Largest shareholders include Laurion Capital Management LP, Vanguard Group Inc, VTSMX - Vanguard Total Stock Market Index …The stock price has increased by +0.66% in the last 52 weeks. The beta is 1.12, so Pyxis Oncology's price volatility has been higher than the market average. Beta (1Y)
About the Pyxis Oncology Inc stock forecast. As of 2023 November 24, Friday current price of PYXS stock is 1.400$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).
BOSTON, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, today announced its participation in two upcoming investment conferences. On September 6, 2023, members of the Pyxis Oncology executive team will host in ...
Nov 24, 2023 · Price Target Based on short-term price targets offered by four analysts, the average price target for Pyxis Oncology, Inc. comes to $7.25. The forecasts range from a low of $2.00 to a high of... As of August 15, 2022, the outstanding number of shares of Common Stock of Pyxis Oncology was 32,834,561. About Pyxis Oncology, Inc. Pyxis Oncology, Inc. is an oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. By leveraging our …Pyxis Oncology continues to advance lead programs ... the outstanding number of shares of Common Stock of Pyxis Oncology was 35,097,256. ... and it is not possible for our management to predict ...Pyxis Oncology, Inc. (PYXS) Share Price Forecast v/s Share Price Today Below is a chart showing the percentage difference between Pyxis Oncology, Inc.'s share price and its median forecast price. As on 27.11.23, the difference is -75.29% Milestone marks transition of Pyxis Oncology to a clinical-stage company Preliminary data anticipated in early 2024 CAMBRIDGE, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc ...About Pyxis Oncology Founded by Longwood Fund, Pyxis Oncology is building a differentiated portfolio of biologics, including antibody-drug conjugates (ADCs) and immunotherapies, to improve the lives of patients with difficult-to-treat cancers. Pyxis is employing site-specific conjugation technology to develop highly stable ADCs with …Pyxis Oncology Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time PYXS stock price.Pyxis Oncology, Inc. (PYXS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.Find the latest Predictive Oncology Inc. (POAI) stock quote, history, news and other vital information to help you with your stock trading and investing.Stock Price Forecast. According to 3 stock analysts, the average 12-month stock price forecast for Pyxis Oncology stock is $12, which predicts an increase of …Gritstone Oncology will release earnings for the most recent quarter on August 4.Analysts expect Gritstone Oncology will report losses per share o... Gritstone Oncology will release figures for Q2 on August 4. In terms of EPS, 4 analysts ar...Nov 30, 2023 · The current price Pyxis Oncology ( PYXS) is trading at is $1.51, which is within the analyst’s predicted range. Browse analyst ratings and price targets on all stocks. Analysts publish ratings ...
Pyxis Oncology (PYXS) Stock Forecast & Price Prediction. Estimation of the future price movement of Pyxis Oncology stock, based on various factors such as ...Based on Pyxis Oncology’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $38 thousand and a GAAP net loss of $19.24 million.Price Target Based on short-term price targets offered by four analysts, the average price target for Pyxis Oncology, Inc. comes to $7.25. The forecasts range from a low of $2.00 to a high of...Instagram:https://instagram. nft drops freeibm stock price dividendtop 5 forex trading platformscanadian stock Detailed statistics for Pyxis Oncology, Inc. (PYXS) stock, including valuation metrics, financial numbers, share information and more. Skip to main content. Log In Free Trial. ... The beta is 1.12, so Pyxis Oncology's price volatility has been higher than the market average. Beta (1Y) 1.12: 52-Week Price Change +0.66%: 50-Day Moving … best nursing liability insurancesandp 100 etf About the Pyxis Oncology Inc stock forecast. As of 2023 November 24, Friday current price of PYXS stock is 1.400$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).38.65K (22.33% of Avg) Complete Pyxis Oncology Inc. stock information by Barron's. View real-time PYXS stock price and news, along with industry-best analysis. barron's auto sales Mar 30, 2023 · March 30, 2023 at 2:16 PM · 2 min read. It’s been a good week for investors of Pyxis Oncology ( NASDAQ:PYXS), to say the least. Over the past 4 sessions Pyxis shares have gained 170%, bringing ... About the Pyxis Oncology Inc stock forecast. As of 2023 November 24, Friday current price of PYXS stock is 1.400$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).